Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
5423-9 CD107b ACnc WBC Pt Qn     DEPRECATED Deprecated CD107b cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5423-9                 0 Deprecated CD107b WBC-aCnc           Arbitrary concentration; CELL MARKERS; LAMP-2; Leukocytes; Lysosome-associated membrane-protein 2; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54230-8 Cell count & Differential panel with Glucose & Protein - CSF Pt Qn     ACTIVE Cell count and Diff panel with Gluc and Prot - Cerebral spinal fluid   PANEL DefinitionDescription                   PANEL.HEM/BC   54230-8         Order       0 Cell cnt & Diff Pnl with Glu & Prot CSF       N   Cell cnt & Diff Pnl with Glu & Prot; Cell Cnt + Diff Pnl; Cerebral spinal fluid; Cerebrospinal Fl; Diff; Diff Pnl; Differl; Differn; Glu; Gluc; Glucoseur; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.27   Panel                   0
54231-6 Semen analysis fertility panel - Semen Pt -     ACTIVE Semen analysis fertility panel   MIN DefinitionDescription                   PANEL.FERT   54231-6         Order       0 Semen analysis fertility Pnl       N   Ejaculate; FERTILITY TESTING; Genitourinary; GU; Pan; PANEL.FERTILITY; Panl; Pnl; Point in time; Random; Sem; Semen analysis fertility Pnl; Seminal fluid; Smn; SMPLS; UniversalLabOrders; URO; Urology 2.73 2.27   Panel                   0
54232-4 Metabolic panel.large animal - Ser/Plas Pt Qn     ACTIVE Metabolic panel.large animal - Serum or Plasma   MIN DefinitionDescription                   PANEL.CHEM   54232-4         Order       0 Metab Pnl.large animal SerPl       N   Chemistry; Metab Pnl.large animal; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.42 2.27   Panel                   0
54233-2 Metabolic panel.small animal - Ser/Plas Pt Qn     ACTIVE Metabolic panel.small animal - Serum or Plasma   MIN DefinitionDescription                   PANEL.CHEM   54233-2         Order       0 Metab Pnl.small animal SerPl       N   Chemistry; Metab Pnl.small animal; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.42 2.27   Panel                   0
54234-0 Cell count & Differential panel with Glucose & Protein - Body fld Pt -     ACTIVE Cell count and Diff panel with Gluc and Prot - Body fluid   MIN DefinitionDescription                   PANEL.HEM/BC   54234-0         Order       0 Cell cnt & Diff Pnl with Glu & Prot Fld       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell cnt & Diff Pnl with Glu & Prot; Cell Cnt + Diff Pnl; Diff; Diff Pnl; Differl; Differn; Fl; Fld; FLU; Fluid; Glu; Gluc; Glucoseur; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; PR; Prot; Random 2.42 2.27   Panel                   0
54235-7 Cortisol challenge panel - Saliva Pt -     ACTIVE Cortisol challenge panel - Saliva (oral fluid)   MIN DefinitionDescription                   PANEL.CHAL   54235-7         Order       0 Cortis chal Pnl Sal       N   17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis chal Pnl; F; hydrocortisone; Oral fluid; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; Sal 2.42 2.27   Panel                   0
54236-5 Cortisol^9 AM 2nd day specimen MCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Mass/volume] in Serum or Plasma --9 AM 2nd day specimen   MIN DefinitionDescription     pg/mL;ug/dL Cortisol at 9:00, 2nd day, was 40 Ã?µg/dl.           CHAL   54236-5         Observation       0 Cortis 9 AM day 2 SerPl-mCnc       N   17-Hydroxycorticosterone; 9 AM day 2; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR 2.4 2.27               ug/dL       0
54237-3 Corticotropin^9 AM 2nd day specimen MCnc Plas Pt Qn     ACTIVE Corticotropin [Mass/volume] in Plasma --9 AM 2nd day specimen   MIN DefinitionDescription     pg/mL;ng/L ACTH at 9:00, 2nd day, was 20 pg/ml.           CHAL   54237-3         Observation       0 ACTH 9 AM day 2 Plas-mCnc       N   9 AM day 2; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Second; Spec; Tumor marker 2.4 2.27               pg/mL       0
54238-1 LDL.oxidized ACnc Ser/Plas Pt Qn     ACTIVE LDL.oxidized [Units/volume] in Serum or Plasma   MIN DefinitionDescription     arb U/L Oxidized LDL are 120 U/l.           CHEM   54238-1         Both       0 LDL.oxidized SerPl-aCnc       N   Arbitrary concentration; Chemistry; oxLDL; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.27               [arb'U]/L       0
54239-9 Cytopathic effect PrThr XXX Pt Ord     ACTIVE Cytopathic effect [Presence] in Specimen   MIN DefinitionDescription       CPE observed, no CPE           MICRO   54239-9         Both       0 Cytopathic effect Spec Ql       N   CPE; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.69 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
5424-7 CD115 ACnc WBC Pt Qn     DEPRECATED Deprecated CD115 cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5424-7                 0 Deprecated CD115 WBC-aCnc           Arbitrary concentration; CELL MARKERS; c-fms; Colony stimulating factor 1R; CSF-1R; Leukocytes; Macrophage colony stimulating factor receptor; M-CSFR; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54240-7 Influenza virus Ag PrThr XXX Pt Ord     ACTIVE Influenza virus Ag [Presence] in Specimen   MIN DefinitionDescription       none           MICRO   54240-7         Both       0 FLUV Ag Spec Ql       N   Antigen; Antigens; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.73 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54241-5 Influenza virus B Ag PrThr Isolate Pt Ord     ACTIVE Influenza virus B Ag [Presence] in Isolate   MIN DefinitionDescription       none           MICRO   54241-5         Both       0 FLUBV Ag Islt Ql       N   Antigen; Antigens; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.56 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54242-3 Influenza virus Prid Isolate Pt Nom     ACTIVE Influenza virus identified in Isolate   NAM DefinitionDescription                   MICRO   54242-3         Both       0 FLUV Islt       N   FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Islt; Isol; Microbiology; Nominal; Point in time; Random 2.79 2.27                     Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; 0
54243-1 Influenza virus RNA Prid XXX Pt Nom Probe   ACTIVE Influenza virus RNA [Identifier] in Specimen by Probe   MIN DefinitionDescription                   MICRO   54243-1   Probe     Both       0 FLUV RNA Spec Probe       N   DNA NUCLEIC ACID PROBE; DNA probe; FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Ribonucleic acid; Spec; To be specified in another part of the message; Unspecified 2.73 2.27                       0
54244-9 Influenza virus Prid XXX Pt Nom     ACTIVE Influenza virus identified in Specimen   NAM DefinitionDescription       Influenza virus serotype or species           MICRO   54244-9         Both       0 FLUV Spec       N   FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.79 2.27                     Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; 0
54245-6 Respiratory virus Ag Prid XXX Pt Nom IF   ACTIVE Respiratory virus Ag [Identifier] in Specimen by Immunofluorescence   MIN DefinitionDescription       parainfluenza virus (1-3), respiratory syscytial virus, metapneumovirus           MICRO   54245-6   IF     Both       0 Resp virus Ag Spec IF       N   ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; ID; Identity or presence; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Resp virus; RV; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified 2.69 2.27                       0
54246-4 Protein & Glucose panel MCnc Body fld Pt Qn     ACTIVE Protein and Glucose panel [Mass/volume] - Body fluid   MIN DefinitionDescription                   PANEL.CHEM   54246-4         Order       0 Prot + Glucose Pnl Fld-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Glu; Gluc; Glucoseur; Level; Mass concentration; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; Prot + Glucose Pnl; QNT; Quan; Quant; Quantitative; Random 2.42 2.27   Panel                   0
54247-2 Drug screen comment Imp Urine Pt Nom     ACTIVE Drug screen comment [Interpretation] in Urine   MIN DefinitionDescription       Narrative result whether the drugs from a specific list are present or not, and also if a specified drug the physician is checking for is present. For example: "Urine presumptive postive for substance(s) with characteristics of: Opiates, Caffeine, Nicotine and metabolite(s). (Not confirmed by alternative method) Unable to screen for the following drugs: Seroquel"           DRUG/TOX   54247-2         Observation       0 Drug screen comment Ur-Imp       N   cmmt; cmnt; Com; Comm; Comments; Commt; DRUG/TOXICOLOGY; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Remarks; Scn; Scr; Scrn; UA; UR; Urn 2.73 2.27                       0
54248-0 Glucose^10M pre dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --10 minutes pre dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54248-0         Observation       0 Glucose 10M pre Gc SerPl-sCnc       N   10M pre Gc; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54249-8 Glucose^15M post dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54249-8         Observation       0 Glucose 15M p Gc SerPl-sCnc       N   15M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
5425-4 CD117 ACnc WBC Pt Qn     DEPRECATED Deprecated CD117 cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5425-4                 0 Deprecated CD117 WBC-aCnc           Arbitrary concentration; CELL MARKERS; c-KIT; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; SCFR; stem cell factor receptor; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54250-6 Glucose^15M pre dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54250-6         Observation       0 Glucose 15M pre Gc SerPl-sCnc       N   15M pre Gc; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54251-4 Glucose^20M post dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54251-4         Observation       0 Glucose 20M p Gc SerPl-sCnc       N   20M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
104,672 results found